Recurrent GBM
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (NCT04681677) | Xoft, Inc. | 2021-11-02 |
| Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT (NCT04763031) | Parkridge Medical Center | 2021-03-05 |
| A Phase I/IIa Study of Cerebraca Wafer Plus Adjuvant Temozolomide (TMZ) in Patients With Recurrent High Grade Glioma (NCT03234595) | Everfront Biotech Co., Ltd. | 2017-11-01 |
| Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut (NCT03068650) | Celldex Therapeutics |
Track Recurrent GBM automatically
Every clearance here is in the API, with alerts when new ones post.